1-11 of 11
Lori J. Wirth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers

Available to Purchase
Michael E. Bryan, Ling Aye, Dipon Das, Shun Hirayama, Yana Al-Inaya, Julia Mendel, Saskia Naegele, Vasileios Efthymiou, Bayan Alzumaili, William C. Faquin, Peter M. Sadow, Derrick Lin, Mark A. Varvares, Allen L. Feng, Daniel G. Deschler, Annie W. Chan, Jonathan Paly, Jong C. Park, Thomas Roberts, Ross Merkin, Sambit K. Mishra, Lea Kröller, Birgitta Michels, A. John Iafrate, Lori J. Wirth, Viktor A. Adalsteinsson, Mathew Crowson, Tim Waterboer, Lisa Mirabello, Michael S. Lawrence, Zoe Guan, Adam S. Fisch, Jeremy D. Richmon, Daniel L. Faden
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF11.
https://doi.org/10.1158/1078-0432.CCR-24-2525
Published: 20 May 2025
View articletitled, Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers
Open the PDF for Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers in another window
Includes: Supplementary data
Journal Articles

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

Available to Purchase
Jena D. French, Bryan R. Haugen, Francis P. Worden, Daniel W. Bowles, Andrew G. Gianoukakis, Bhavana Konda, Ramona Dadu, Eric J. Sherman, Shaylene McCue, Nathan R. Foster, Yuri E. Nikiforov, Ticiana D.J. Farias, Paul J. Norman, Lori J. Wirth
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3757–3767.
https://doi.org/10.1158/1078-0432.CCR-23-3417
Published: 03 September 2024
View articletitled, Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers
Open the PDF for Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers in another window
Includes: Supplementary data
Journal Articles

Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer

Available to Purchase
Giulia Siravegna, Connor J. O'Boyle, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Jarrod Stein, Julia Thierauf, Peter M. Sadow, William C. Faquin, Simon K. Perry, Adam Z. Bard, Wei Wang, Daniel G. Deschler, Kevin S. Emerick, Mark A. Varvares, Jong C. Park, John R. Clark, Annie W. Chan, Vanessa Carlota Andreu Arasa, Osamu Sakai, Jochen Lennerz, Ryan B. Corcoran, Lori J. Wirth, Derrick T. Lin, A. John Iafrate, Jeremy D. Richmon, Daniel L. Faden
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 719–727.
https://doi.org/10.1158/1078-0432.CCR-21-3151
Published: 15 February 2022
View articletitled, Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Open the PDF for Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

Free
Glenn J. Hanna, Naifa L. Busaidy, Nicole G. Chau, Lori J. Wirth, Justine A. Barletta, Antonio Calles, Robert I. Haddad, Stefan Kraft, Maria E. Cabanillas, Guilherme Rabinowits, Anne O'Neill, Sewanti A. Limaye, Erik K. Alexander, Francis D. Moore, Jr, Krystof Misiwkeiwicz, Tom Thomas, Matthew Nehs, Ellen Marqusee, Stephanie L. Lee, Pasi A. Jänne, Jochen H. Lorch
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (7): 1546–1553.
https://doi.org/10.1158/1078-0432.CCR-17-2297
Published: 02 April 2018
View articletitled, Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Open the PDF for Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study in another window
Includes: Supplementary data
Journal Articles

Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib—Response

Free
S. Michael Rothenberg, Gilbert H. Daniels, Lori J. Wirth
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5640–5641.
https://doi.org/10.1158/1078-0432.CCR-15-2298
Published: 14 December 2015
View articletitled, Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib—Response
Open the PDF for Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib—Response in another window
Journal Articles

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

Free
Thomas J. Galloway, Lori J. Wirth, Alexander D. Colevas, Jill Gilbert, Julie E. Bauman, Nabil F. Saba, David Raben, Ranee Mehra, Anna W. Ma, Ruzanna Atoyan, Jing Wang, Barbara Burtness, Antonio Jimeno
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1566–1573.
https://doi.org/10.1158/1078-0432.CCR-14-2820
Published: 31 March 2015
View articletitled, A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
Open the PDF for A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib

Free
S. Michael Rothenberg, David G. McFadden, Edwin L. Palmer, Gilbert H. Daniels, Lori J. Wirth
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1028–1035.
https://doi.org/10.1158/1078-0432.CCR-14-2915
Published: 01 March 2015
View articletitled, Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
Open the PDF for Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors

Free
Jonathan Goldman, S. Gail Eckhardt, Mitesh J. Borad, Kelly K. Curtis, Manuel Hidalgo, Emiliano Calvo, David P. Ryan, Lori J. Wirth, Asit Parikh, James Partyka, Helene Faessel, Esha Gangolli, Sally Stewart, Lee S. Rosen, Daniel W. Bowles
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (5): 1002–1009.
https://doi.org/10.1158/1078-0432.CCR-14-1234
Published: 01 March 2015
View articletitled, Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment

Free
Valentina Nardi, Peter M. Sadow, Dejan Juric, Dave Zhao, Arjola K. Cosper, Kristin Bergethon, Vanessa L. Scialabba, Julie M. Batten, Darrell R. Borger, Anthony John Iafrate, Rebecca S. Heist, Donald P. Lawrence, Keith T. Flaherty, Johanna C. Bendell, Daniel Deschler, Yi Li, Lori J. Wirth, Dora Dias-Santagata
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 480–490.
https://doi.org/10.1158/1078-0432.CCR-12-1842
Published: 16 January 2013
View articletitled, Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment
Open the PDF for Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment in another window
Journal Articles

Reply

Free
Lori J. Wirth, Arthur T. Skarin, David J. Sugarbaker
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2904.
https://doi.org/10.1158/1078-0432.2904.10.8
Published: 15 April 2004
View articletitled, Reply
Open the PDF for Reply in another window
Journal Articles

Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer: A Phase I Study

Free
Lori J. Wirth, Joan Lucca, Patricia Ostler, Panos Fidias, Cathy Lynch, Pasi A. Jänne, Roy S. Herbst, Bruce E. Johnson, David J. Sugarbaker, Douglas J. Mathisen, Jeanne M. Lukanich, Noah C. Choi, Stuart M. Berman, Arthur T. Skarin
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (5): 1698–1704.
Published: 01 May 2003
View articletitled, Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer: A Phase I Study
Open the PDF for Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, then Surgery in Stage III Non-Small Cell Lung Cancer: A Phase I Study in another window